[unable to retrieve full-text content]
Merck shares gained 3.8% in after-hours trading Tuesday following approval of its new drug for a potentially fatal lung disease.
[unable to retrieve full-text content]
Merck shares gained 3.8% in after-hours trading Tuesday following approval of its new drug for a potentially fatal lung disease.
Brainfind is your one-stop shop for breaking news headlines and personalized news stories. Not only are we a news aggregator and content curator, we also allow registered users to publish their own articles on our website with full credit and their social links.